<DOC>
	<DOCNO>NCT03083561</DOCNO>
	<brief_summary>The main purpose study evaluate safety tolerability LY3337641 healthy Japanese Caucasian participant . The study also investigate body process LY3337641 effect LY3337641 body . The study last 4 week participant . Screening may occur within 28 day prior first dose study drug .</brief_summary>
	<brief_title>A Study LY3337641 Japanese Caucasian Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Overtly healthy Japanese Caucasian Body mass index ( BMI ) 18.0 32.0 kilogram per square meter ( kg/mÂ² ) Are currently enrol clinical trial involve investigational product offlabel use drug device concurrently enrol type medical research judge scientifically medically compatible study Have participate , within last 30 day , clinical trial involve investigational product . If previous investigational product long halflife , 3 month 5 halflives ( whichever longer , know ) pass Have abnormality 12lead electrocardiogram ( ECG ) , opinion investigator , increase risk associate participate study affect confound QTc analysis Fridericiacorrected QT interval ( QTcF ) &gt; 450 millisecond ( msec ) males &gt; 470 msec female Have symptomatic herpes zoster within 3 month screen Have active latent tuberculosis ( TB ) base positive medical history , examination , and/or TB test result . Have receive live vaccine ( ) within 1 month screen intend study Are immunocompromised Have history constipation acute constipation within 3 week prior admission</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>